Increased risk of major congenital malformations in early pregnancy use of angiotensin-converting-enzyme inhibitors and angiotensin-receptor-blockers: a meta-analysis,Diabetes/Metabolism Research and Reviews

当前位置： X-MOL 学术 › Diabetes Metab. Res. Rev. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Increased risk of major congenital malformations in early pregnancy use of angiotensin-converting-enzyme inhibitors and angiotensin-receptor-blockers: a meta-analysis
Diabetes/Metabolism Research and Reviews ( IF 8 ) Pub Date : 2021-03-29 , DOI: 10.1002/dmrr.3453
Jennifer Fu ₁ , George Tomlinson _{1,

2} , Denice S Feig _{1,

3,

4}

Affiliation

To evaluate the risk of adverse fetal outcomes after exposure to angiotensin converting enzyme inhibitors (ACE-Is) or angiotensin receptor blockers (ARBs) in first trimester of pregnancy, by conducting a systematic review and meta-analysis.

中文翻译：